A Study of LY3002813 in Participants With Memory Damage Due to Alzheimer's Disease (AD) or AD

Exclusion Criteria

• •Do not have up to 2 reliable partners who are in frequent contact with the participant, who will accompany the participant to the office and/or be available by telephone at designated times, and will monitor administration of prescribed medications
• •Are being monitored for radiation due to occupational exposure to ionized radiation, or exposure to ionizing radiation within last 12 months from an investigational study
• •History of intracranial hemorrhage, cerebrovascular aneurysm or arteriovenous malformation, or carotid artery occlusion, or stroke or epilepsy
• •Have any contraindications for magnetic resonance imaging (MRI) studies, including claustrophobia, the presence of contraindicated metal (ferromagnetic) implants, cardiac pacemaker
• •Have allergies to humanized monoclonal antibodies, including proteins and diphenhydramine, epinephrine, and methylprednisolone
• •Have gamma globulin therapy within the last year
• •Previously dosed in any other study investigating active immunization against amyloid beta (Aβ)
• •Previously dosed in any other study investigating passive immunization against Aβ within the last 6 months
• •Have current serious or unstable illnesses